iRhythm Holdings, Inc. (FRA:I25)

Market Cap	4.14B +24.0%
Revenue (ttm)	636.34M +26.2%
Net Income	-37.94M
EPS	-1.19
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	0
Open	134.00
Previous Close	127.00
Day's Range	134.00 - 135.00
52-Week Range	84.50 - 179.00
Beta	n/a
RSI	55.58
Earnings Date	Feb 19, 2026

About iRhythm Holdings

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2006
• Employees: 2,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: I25

Financial Performance

In 2025, iRhythm Holdings's revenue was $747.14 million, an increase of 26.24% compared to the previous year's $591.84 million. Losses were -$44.55 million, -60.67% less than in 2024.

Financial numbers in USD